Nifty
Sensex
:
:
25935.15
84273.92
67.85 (0.26%)
208.17 (0.25%)

Pharmaceuticals & Drugs - Global

Rating :
43/99

BSE: 506690 | NSE: UNICHEMLAB

386.35
10-Feb-2026
  • Open
  • High
  • Low
  • Previous Close
  •  395
  •  397.95
  •  382.55
  •  396.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  46710
  •  18196661.15
  •  729.8
  •  361.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,716.96
  • 9.21
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,997.00
  • N/A
  • 1.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.22%
  • 0.46%
  • 15.18%
  • FII
  • DII
  • Others
  • 0.99%
  • 9.39%
  • 3.76%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.71
  • 11.31
  • 16.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.92
  • 23.79
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.40
  • 31.73
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.23
  • 1.24
  • 1.51

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.14
  • 19.66
  • 18.80

Earnings Forecasts:

(Updated: 07-02-2026)
Description
2024
2025
2026
2027
Adj EPS
19.53
P/E Ratio
19.78
Revenue
2064.48
EBITDA
264.86
Net Income
137.52
ROA
4.02
P/B Ratio
1.11
ROE
5.63
FCFF
-162.26
FCFF Yield
-4.95
Net Debt
342.14
BVPS
348.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
521.17
533.09
-2.24%
578.96
507.36
14.11%
526.60
483.34
8.95%
587.18
459.60
27.76%
Expenses
476.39
447.57
6.44%
512.78
451.87
13.48%
504.11
443.19
13.75%
503.48
437.97
14.96%
EBITDA
44.78
85.52
-47.64%
66.18
55.49
19.26%
22.49
40.15
-43.99%
83.70
21.63
286.96%
EBIDTM
8.59%
16.04%
11.43%
10.94%
4.27%
8.31%
14.25%
4.71%
Other Income
11.80
13.62
-13.36%
20.97
8.69
141.31%
6.82
3.76
81.38%
9.25
6.15
50.41%
Interest
7.42
6.75
9.93%
8.24
4.79
72.03%
6.54
4.03
62.28%
5.46
4.59
18.95%
Depreciation
31.25
30.54
2.32%
31.47
32.26
-2.45%
31.79
32.07
-0.87%
29.69
30.88
-3.85%
PBT
293.43
61.85
374.42%
-10.82
27.13
-
-9.02
7.81
-
57.80
-133.31
-
Tax
29.14
4.00
628.50%
1.07
2.50
-57.20%
1.45
5.74
-74.74%
4.83
3.43
40.82%
PAT
264.29
57.85
356.85%
-11.89
24.63
-
-10.47
2.07
-
52.97
-136.74
-
PATM
50.71%
10.85%
-2.05%
4.85%
-1.99%
0.43%
9.02%
-29.75%
EPS
37.54
8.22
356.69%
-1.69
3.50
-
-1.49
0.29
-
7.52
-19.42
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
2,213.91
2,110.97
1,785.11
1,343.02
1,269.83
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
Net Sales Growth
11.62%
18.25%
32.92%
5.76%
2.81%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
 
Cost Of Goods Sold
1,017.10
751.11
637.70
482.45
356.91
302.14
308.63
364.19
274.97
188.77
386.97
Gross Profit
1,196.81
1,359.86
1,147.41
860.57
912.92
933.00
795.08
823.99
1,104.93
1,351.28
945.67
GP Margin
54.06%
64.42%
64.28%
64.08%
71.89%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
Total Expenditure
1,996.76
1,846.11
1,698.23
1,388.58
1,197.04
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
Power & Fuel Cost
-
108.16
107.14
102.84
78.05
68.89
73.02
76.39
49.23
41.62
38.25
% Of Sales
-
5.12%
6.00%
7.66%
6.15%
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
Employee Cost
-
402.21
403.20
356.41
330.49
306.97
273.28
238.52
200.64
169.04
255.92
% Of Sales
-
19.05%
22.59%
26.54%
26.03%
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
Manufacturing Exp.
-
242.87
227.83
194.60
193.21
215.73
232.08
147.23
125.30
103.70
150.54
% Of Sales
-
11.51%
12.76%
14.49%
15.22%
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
General & Admin Exp.
-
139.75
138.44
119.02
109.60
123.98
147.90
229.37
594.53
744.66
167.66
% Of Sales
-
6.62%
7.76%
8.86%
8.63%
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
Selling & Distn. Exp.
-
202.01
183.92
129.56
120.68
122.52
116.12
197.24
108.38
107.77
166.84
% Of Sales
-
9.57%
10.30%
9.65%
9.50%
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
Miscellaneous Exp.
-
0.00
0.00
3.70
8.11
3.81
3.50
16.26
5.16
2.06
166.84
% Of Sales
-
0%
0%
0.28%
0.64%
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
EBITDA
217.15
264.86
86.88
-45.56
72.79
91.11
-50.82
-81.02
21.69
182.44
163.88
EBITDA Margin
9.81%
12.55%
4.87%
-3.39%
5.73%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
Other Income
48.84
35.32
31.59
38.52
47.51
50.19
91.31
98.41
3,278.19
5.50
19.11
Interest
27.66
21.03
22.66
17.31
6.11
5.12
7.85
7.52
8.01
3.36
2.90
Depreciation
124.20
124.56
123.16
113.44
91.17
84.36
81.67
67.37
50.51
43.52
38.79
PBT
331.39
154.59
-27.35
-137.80
23.03
51.82
-49.02
-57.50
3,241.36
141.07
141.31
Tax
36.49
17.07
8.80
25.86
-11.09
17.15
11.97
-33.64
696.23
32.58
29.30
Tax Rate
11.01%
11.04%
-10.36%
-14.66%
-48.15%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
PAT
294.90
137.52
-93.76
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
PAT before Minority Interest
294.90
137.52
-93.76
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
13.32%
6.51%
-5.25%
-15.06%
2.60%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
PAT Growth
665.05%
-
-
-
-4.64%
-
-
-
2,245.96%
0.01%
 
EPS
41.89
19.53
-13.32
-28.73
4.70
4.92
-8.66
-3.39
361.52
15.41
15.41

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,450.59
2,438.30
2,435.30
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
Share Capital
14.08
14.08
14.08
14.08
14.08
14.08
14.08
14.07
18.18
18.17
Total Reserves
2,431.39
2,421.16
2,409.18
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
Non-Current Liabilities
98.72
92.27
108.03
143.88
49.16
43.72
10.10
46.46
64.49
76.02
Secured Loans
60.81
38.22
63.65
89.01
0.00
0.00
0.00
0.33
0.44
22.98
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
37.86
35.80
41.91
39.96
30.41
23.51
14.60
10.76
25.33
12.58
Current Liabilities
991.97
737.60
639.60
552.13
505.76
566.73
502.92
463.51
392.62
275.09
Trade Payables
402.55
351.26
290.69
183.19
210.08
250.22
221.41
226.23
210.73
163.95
Other Current Liabilities
107.15
93.01
128.34
135.06
176.97
122.04
68.45
63.03
68.01
60.56
Short Term Borrowings
340.29
155.27
208.08
215.69
100.63
184.03
199.67
150.29
97.62
12.93
Short Term Provisions
141.98
138.06
12.50
18.19
18.09
10.44
13.39
23.97
16.25
37.65
Total Liabilities
3,541.28
3,268.17
3,182.93
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
Net Block
1,299.57
1,252.40
1,256.66
990.03
880.42
866.06
806.29
574.45
487.22
402.60
Gross Block
1,993.53
1,919.54
1,750.29
1,379.74
1,193.56
1,098.27
975.96
689.74
561.37
439.53
Accumulated Depreciation
693.96
667.14
493.63
389.70
313.14
232.21
169.67
115.29
74.15
36.92
Non Current Assets
1,505.67
1,521.50
1,591.06
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
Capital Work in Progress
30.67
122.71
147.45
493.81
567.50
330.47
92.39
238.15
249.98
237.13
Non Current Investment
0.02
0.02
0.16
0.28
159.12
134.38
129.20
9.20
9.51
5.54
Long Term Loans & Adv.
150.61
124.92
168.07
165.59
112.89
112.90
56.37
24.05
25.57
28.05
Other Non Current Assets
24.80
21.45
18.72
16.30
14.52
11.52
9.39
7.74
0.00
0.00
Current Assets
2,029.47
1,743.32
1,588.47
1,644.92
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
Current Investments
0.00
1.34
1.54
263.58
236.43
419.10
800.75
895.55
8.00
8.04
Inventories
988.74
736.26
625.23
600.22
538.34
396.54
338.66
272.86
281.71
230.57
Sundry Debtors
778.81
642.31
588.62
495.43
250.27
390.14
436.05
276.92
315.32
220.09
Cash & Bank
117.63
158.16
185.36
114.10
82.45
233.81
200.99
681.46
16.14
20.13
Other Current Assets
144.29
29.79
31.31
34.60
269.83
246.88
262.83
209.68
127.29
153.28
Short Term Loans & Adv.
101.58
175.46
156.40
136.99
207.62
183.04
194.18
145.51
98.80
122.77
Net Current Assets
1,037.50
1,005.72
948.86
1,092.80
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
Total Assets
3,535.14
3,264.82
3,179.53
3,310.94
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-7.02
14.00
-85.09
-259.61
32.98
19.82
-327.77
-112.34
68.19
111.91
PBT
154.59
-84.96
-176.36
21.97
51.48
-48.21
-57.44
3,241.14
141.25
137.68
Adjustment
148.70
197.32
132.84
80.46
65.65
18.79
6.80
-3,207.66
53.31
39.65
Changes in Working Capital
-293.89
-91.99
-29.36
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
-34.16
Cash after chg. in Working capital
9.40
20.37
-72.88
-252.00
47.35
24.15
-315.57
-113.20
95.91
143.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-16.42
-6.37
-12.21
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-241.23
50.40
202.81
102.40
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
Net Fixed Assets
-115.91
-1.93
-20.93
-121.73
-327.70
-338.73
-139.02
-107.71
-135.60
154.89
Net Investments
-1.54
-3.56
349.28
134.15
147.92
374.24
-63.59
-889.36
17.40
42.09
Others
-123.78
55.89
-125.54
89.98
106.22
-71.42
-83.40
2,645.40
-9.67
-282.31
Cash from Financing Activity
183.76
-106.31
-81.30
191.23
-121.07
-62.30
-2.42
-881.13
59.23
-33.42
Net Cash Inflow / Outflow
-64.49
-41.91
36.42
34.01
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
Opening Cash & Equivalents
154.75
183.75
109.20
77.46
231.52
197.05
666.07
11.21
11.67
26.96
Closing Cash & Equivalent
89.58
154.75
183.75
109.20
77.46
231.52
197.05
666.07
11.21
20.13

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
347.37
345.91
344.18
370.38
362.05
358.85
371.69
380.95
116.88
104.93
ROA
4.04%
-2.91%
-6.22%
1.03%
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
ROE
5.64%
-3.86%
-8.04%
1.28%
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
ROCE
6.34%
-2.31%
-5.60%
1.00%
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
Fixed Asset Turnover
1.08
0.97
0.86
0.99
1.08
1.06
1.43
2.21
3.08
2.32
Receivable days
122.86
125.84
147.31
107.17
94.63
136.61
109.51
78.30
63.41
55.72
Inventory Days
149.13
139.19
166.52
163.63
138.14
121.57
93.93
73.33
60.67
59.32
Payable days
183.16
183.72
179.25
201.09
278.03
76.39
73.41
94.97
104.25
52.00
Cash Conversion Cycle
88.84
81.32
134.58
69.71
-45.27
181.78
130.03
56.65
19.82
63.05
Total Debt/Equity
0.18
0.09
0.12
0.13
0.04
0.07
0.08
0.06
0.09
0.04
Interest Cover
8.35
-2.75
-9.19
4.60
11.12
-5.25
-6.64
405.79
43.00
48.57

News Update:


  • Unichem Lab - Quarterly Results
    6th Feb 2026, 00:00 AM

    Read More
  • USFDA concludes inspection at Unichem Laboratories’ Kolhapur API facility
    3rd Feb 2026, 10:09 AM

    The inspection closed with five observations which were more of procedural changes with none of these related to data integrity

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.